The mechanism of preventive effect of captopril on renal ischemia reperfusion injury is independent of ATP dependent potassium channels

Iranian Biomedical Journal

Volumn 12, Issue 4, 2008, Pages 241-245

  Habibey, Rouhollah ^a   Ajami, Marjan ^a   Hesami, Ali ^b   Pazoki Toroudi, Hamidreza ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MILAD HOSPITAL   (Iran)

Author keywords

Angiotensin converting enzyme (ace) inhibitors; Angiotensin ii; Captopril; Glibenclamide, katp channels

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; GLIBENCLAMIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; KIDNEY ISCHEMIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; KATP CHANNELS; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

ANIMALIA; RATTUS;

EID: 61349163548     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ciao, H., Kodak, Y., McElroy, P., Craig, L., Housini, I. and Star, R.A. (1997) α-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99:1165-1172.
2. Maxwell, S.R.J. and Lip, G.Y.H. (1997) Reperfusion injury: a review of the pathophysiology, clinical manifestation and therapeutic options. Int. J. Cardiol. 58: 95-117.
3. Adam, A. and Raij, L. (2000) Nitric oxide-angiotensin II axis in renal and cardiovascular injury. J. Nephrol. 13: 211-220.
4. Wolf, G. (1999) Angiotensin II: a pivotal factor in the progression of renal diseases. Nephrol. Dial. Transplant. 14 Suppl 1: 42-44.
5. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F., Motolese, M., Ponticelli, C., Ritz, E. and Zucchelli, P. (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group. N. Engl. J. Med. 334: 939-945.
6. Wolf, G. and Ziyadeh, F.N. (1997) The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am. J. Kidney. Dis. 29: 153-163.
7. Wang, Y.G. and Lipsius, S.L. (1995) Acetylcholine activates a glibenclamide-sensitive K+ current in cat atrial myocytes. Am. J. Physiol. 268: H1322-H1334.
8. Light, P.E., Allen, B.G., Walsh, M.P. and French, R.J. (1995) Regulation of adenosine triphosphate- sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochemistry 34: 7252-7257.
9. Baker, K.M., Singer, H.A. and Aceto, J.F. (1989) Angiotensin II receptor-mediated stimulation of cytosolic-free calcium and inositol phosphates in chick myocytes. J. Pharmacol. Exp. Ther. 251: 578-585.
10. + current in human and rabbit ventricular myocytes. Circ. Res. 78: 492-498.
11. + channels: a possible mechanistic link to ischemic preconditioning. Circ. Res. 79: 399-406.
12. + channels in cardiac muscle. Nature 305:147-148.
13. Nabika, T., Velletri, P.A. and Lovenberg, W. (1985) Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [Arg] vasopressin in vascular smooth muscle cells. J. Biol. Chem. 260: 4661-4670.
14. Gross, G.J. and Auchanpach, J.A. (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233.
15. Gardiner, S.M., Kemp, P.A., March, J.E., Fallgren, B. and Bennett, T. (1996) Effects of glibenclamide on the regional haemodynamic actions of -trinositol and its influence on responses to vasodilators in conscious rats. Br. J. Pharmacol. 117: 507-515.
16. Sadowski, J., Kompanowska-Jezierska, E., Dobrowolski, L., Walkowska, A. and Badzynska, B. (1997) Simultaneous recording of tissue ion content and blood flow in rat renal medulla: evidence on interdependence. Am. J. Physiol. Renal. Physiol. 273: F658-F662.
17. Cao, C., Lee-Kwon, W., Silldorff, E.P. and Pallone, T.L. (2005) KATP channel conductance of descending vasa recta pericytes. Am. J. Physiol. Renal. Physiol. 289: F1235-F1245.
18. Hayabuchi, Y., Davies, N.W. and Standen, N.B. (2001) Angiotensin II inhibits rat arterial KATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase C. J. Physiol. 530: 193-205.
19. Koppel, H., Gasser, R., Klein, W. and Holzmann, S. (1996) ACE inhibitors with SH groups have no effect of ATP-dependent K channels-a dissertation. Acta. Med. Austriaca. 23: 109-112.
20. Jablonski, P., Howden, B.O., Rae, D.A., Birrell, C.S., Marshall, V.C. and Tange, A.J. (1983) Experimental model for assessment of renal recovery from warm ischemia. Transplantation 35: 198-204.
21. Kubo, M., Quayle, J.M. and Standen, N.B. (1997) Angiotensin II inhibition of ATP-sensitive K+ currents in rat arterial smooth muscle cells through protein kinase C. J. Physiol. 503: 489-496.
22. Thous, D.W., Baker, K.M., Ayers, C.R., Vaughan, E.D. and Carley, R.M. (1980) Acute and chronic effect of captopril in hypertensive patients. Hypertension 2: 567-575.
23. Elfellah, M.S. and Oglive, R.I. (1985) Effect of vasodilator drugs on coronary occlusion and reperfusion arrhythmias in anaesthetized dogs. J. Cardiovasc. Pharmacol. 7: 826-832.
24. Van Gilst, W.H., De Graeff, P.A., Wesseling, H. and de Langen, C.D.J. (1986) Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril and HOE 498. J. Cardiovasc. Pharmacol. 8: 722-728.
25. Hirakata, H., Found-Tarazi, F.M., Bumpus, F.M., Khosla, M. and Healy, B. (1990) Angiotensins and the failing heart: enhanced positive inotropic response to angiotensin-I in cardiomyopathic hamster heart in the presence of captopril. Circ. Res. 66: 891-899.
26. Urata, H., Kinosita, A., Misono, K.S., Bumpus, F.M. and Fusain, A. (1990) Identification of a highly specific chymase as the major angiotensin-II-forming enzyme in the human heart. J. Biol. Chem. 265: 22348-22357.
27. Yatsu, T., Aoki, M., Uchida, W. and Inagaki, O. (2005) Comparison between YM099 and captopril in rats with renal mass reduction-induced progressive renal disease. Biol. Pharm. Bull. 28: 367-369.
28. Pazoki-Toroudi, H.R., Hesami, A., Vahidi, S., Sahebjam, F., Seifi, B. and Djahanguiri, B. (2003) The preventive effect of captopril or enalapril on reperfusion injury of the kidney of rats is independent of angiotensin II AT1 receptors. Fundam. Clin. Pharmacol. 17 (5): 595-598.